Jeannette Potts
Compliance Officer bei UNIQURE N.V.
Vermögen: 478 170 $ am 31.05.2024
Profil
Jeannette Potts is currently working as the Secretary, Senior Vice President & General Counsel at Forma Therapeutics Holdings, Inc. and as the Chief Legal & Compliance Officer at uniQure NV.
Previously, she worked as the Director-Marketing & Sales at Viroblock SA and as the Associate General Counsel at Millennium Pharmaceuticals, Inc. She also served as the VP, Head Counsel-Research & Development at Takeda Pharmaceuticals U.S.A., Inc. from 2013 to 2019.
Dr. Potts holds a doctorate degree from the University of Virginia, an undergraduate degree from Smith College, a graduate degree from Suffolk University, and an undergraduate degree from Trinity College Dublin.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
UNIQURE N.V.
0,20% | 01.03.2024 | 96 600 ( 0,20% ) | 478 170 $ | 31.05.2024 |
Aktive Positionen von Jeannette Potts
| Unternehmen | Position | Beginn |
|---|---|---|
| FORMA THERAPEUTICS HOLDINGS, INC. | General Counsel | 01.09.2019 |
| UNIQURE N.V. | Compliance Officer | - |
Ehemalige bekannte Positionen von Jeannette Potts
| Unternehmen | Position | Ende |
|---|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2019 |
Viroblock SA
 Viroblock SA Miscellaneous Commercial ServicesCommercial Services Viroblock SA develops and commercializes antiviral products. Viroblock technology uses a novel mechanism of action to inactivate enveloped viruses, human and avian such As influenzas, SARS virus and the AIDS virus. The company was founded by Donald F. H. Wallach in 2005 and is headquartered in Irvine, CA. | Vertrieb & Marketing | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Ausbildung von Jeannette Potts
| Smith College | Undergraduate Degree |
| University of Virginia | Doctorate Degree |
| Suffolk University | Graduate Degree |
| Trinity College Dublin | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| UNIQURE N.V. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Forma Therapeutics Holdings, Inc.
 Forma Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Forma Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company. engages in the research, development and commercialization of novel therapeutics for the treatment of hematologic diseases and cancers. Its product pipeline consists of FT-4202 for the treatment of sickle cell disease and other hemoglobinopathies, and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company was founded by Michael A. Foley in December 2011 and is headquartered in Watertown, MA. | Health Technology |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Viroblock SA
Viroblock SA Miscellaneous Commercial ServicesCommercial Services Viroblock SA develops and commercializes antiviral products. Viroblock technology uses a novel mechanism of action to inactivate enveloped viruses, human and avian such As influenzas, SARS virus and the AIDS virus. The company was founded by Donald F. H. Wallach in 2005 and is headquartered in Irvine, CA. | Commercial Services |
